[ASAP] Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase Inhibitors through Liver Targeting

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.0c00640

Source: Journal of Medicinal Chemistry - September 18, 2020 Category: Chemistry Authors: Kim Huard, Aaron C. Smith, Gregg Cappon, Robert L. Dow, David J. Edmonds, Ayman El-Kattan, William P. Esler, Dilinie P. Fernando, David A. Griffith, Amit S. Kalgutkar, Trenton T. Ross, Scott W. Bagley, David Beebe, Yi-An Bi, Shawn Cabral, Collin Crowley, Source Type: research